2021
DOI: 10.3389/fmed.2021.705515
|View full text |Cite
|
Sign up to set email alerts
|

Risk Stratification Model for Predicting the Overall Survival of Elderly Triple-Negative Breast Cancer Patients: A Population-Based Study

Abstract: Background: The objective of this study was to evaluate the prognostic value of clinical characteristics in elderly patients with triple-negative breast cancer (TNBC).Methods: The cohort was selected from the Surveillance, Epidemiology, and End Results (SEER) program dating from 2010 to 2015. Univariate and multivariate analyses were performed using a Cox proportional risk regression model, and a nomogram was constructed to predict the 1-, 3-, and 5-year prognoses of elderly patients with TNBC. A concordance i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
4
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 30 publications
0
4
2
Order By: Relevance
“…Furthermore, the recommended surgical modalities proposed for TNBC remain controversial ( 16 , 18 , 19 , 21 23 ). When compared to published data from older counterparts, a higher proportion of young patients with TNBC in our study were African-American, had histologic types other than IDC and ILC, had grade III and undifferentiated diseases, presented with more advanced T and N stage, and had received chemotherapy ( 32 ). Furthermore, both T stage and N stage are strongly associated with prognosis regardless of age ( 32 ).…”
Section: Discussioncontrasting
confidence: 58%
See 2 more Smart Citations
“…Furthermore, the recommended surgical modalities proposed for TNBC remain controversial ( 16 , 18 , 19 , 21 23 ). When compared to published data from older counterparts, a higher proportion of young patients with TNBC in our study were African-American, had histologic types other than IDC and ILC, had grade III and undifferentiated diseases, presented with more advanced T and N stage, and had received chemotherapy ( 32 ). Furthermore, both T stage and N stage are strongly associated with prognosis regardless of age ( 32 ).…”
Section: Discussioncontrasting
confidence: 58%
“…When compared to published data from older counterparts, a higher proportion of young patients with TNBC in our study were African-American, had histologic types other than IDC and ILC, had grade III and undifferentiated diseases, presented with more advanced T and N stage, and had received chemotherapy ( 32 ). Furthermore, both T stage and N stage are strongly associated with prognosis regardless of age ( 32 ). However, compared to patients with TNBC overall ( 32 , 33 ), the prognoses of those who were young were not associated with tumor grade, chemotherapy, or radiotherapy according to our multivariable Cox analysis, whereas marital and health insurance statuses were.…”
Section: Discussioncontrasting
confidence: 58%
See 1 more Smart Citation
“…Further, the late hypofractionated accelerated radiotherapy with the dose of 50–52 ​Gy, which was assumed to be relatively safe for breast carcinoma treatment, resulted in 2.2% symptomatic breast oedema, 1.9% asymptomatic fibrosis, 2.2% contralateral breast, 3.7% arm lymphedema, and 1.6% other melanoma in 290 investigated patients during amifostine abridged primary radiotherapy dermatitis [ 213 ]. However, radiation therapy could only recover the prognosis risk in the low-risk TNBC population (P ​= ​0.00056), and revealed non-significant betterment in medium and high-risk patients with short existence duration and mortality within 5 years from diagnosis due to the acquirement of radiotherapy tolerance [ 214 ]. Moreover, radiotherapy impairs healthy cells surrounding by tumour cells, induces a rare tumour named angiosarcoma, heaviness and swelling in the breast, numerical/copy number alteration and structural chromosomal aberrations, and infertility [ 210 ].…”
Section: Ongoing Treatments For Triple-negative Breast Cancermentioning
confidence: 99%
“…to assist physicians in optimizing clinical decisions and significantly reduce the psychological distress of survivors. However, to our knowledge, although many TNBC prognostic assessment tools have been developed (9,(20)(21)(22)(23)(24)(25)(26)(27), they have never focused on prognostic changes over time. In addition, the common nomograms, while allowing for individualized prediction, have never provided dynamic prognostic information over survival time.…”
Section: Introductionmentioning
confidence: 99%